This research initiative at Sidra Medicine focuses on discovering biomarkers as part of precision medicine efforts. By leveraging digital data and advanced technologies, the project aims to enhance the early diagnosis and understanding of autism spectrum disorder. Biomarkers are measurable biological signals from the body or brain that provide researchers with objective indicators of autism, offering greater consistency than behavioral observation alone.

The study explores how artificial intelligence can analyze vocal patterns, eye gaze, facial expressions, and other physiological and behavioral signals to support earlier and more accurate diagnoses. Identifying these biological markers helps enable more objective assessments while deepening scientific understanding of the underlying biological processes associated with autism.

Through this cutting-edge precision health approach, the initiative seeks to ensure children receive timely detection and early intervention. By integrating advanced technology with clinical expertise, the program is working to transform how autism is identified and understood, ultimately improving access to support and long-term outcomes.